Metformin Unveils Its Hidden Talent in Cancer Prevention
Metformin, a diabetes medication, has been linked to a reduced risk of developing myeloproliferative neoplasms (MPN), according to a study in Blood Advances. The research shows metformin’s potential beyond diabetes management, with its anti-inflammatory …